Key terms

About AGEN

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest AGEN news

Apr 12 7:34am ET Agenus announces updated results from BOT/BAL combination therapy trial by TipRanks Apr 11 7:50pm ET Agenus trading halted, news pending by TipRanks Apr 05 4:31pm ET Agenus announces 1-for-20 reverse stock split by TipRanks Mar 19 2:30am ET Analysts’ Top Healthcare Picks: Compass Therapeutics (CMPX), Guardant Health (GH) by TipRanks Mar 18 8:52am ET Agenus price target lowered to $5 from $6 at B. Riley by TipRanks Mar 16 2:01am ET Agenus Inc.’s Future at Risk: Concerns Over Financial Health and Operational Viability by TipRanks Mar 15 12:45pm ET Buy Rating Affirmed for Agenus Amidst Promising Cancer Immunotherapy Developments and Strategic Financial Moves by TipRanks Mar 14 11:15am ET Agenus Poised for Growth: Anticipated BLA Filing and Promising Clinical Data Underpin Buy Rating by TipRanks Mar 11 8:00am ET Options Volatility and Implied Earnings Moves This Week, March 11 – March 15, 2024 by TipRanks Mar 06 2:35pm ET Agenus’s Promising Botensilimab Leads to Buy Rating from Analyst Mayank Mamtani by TipRanks Feb 15 8:12am ET Agenus Announces 1:20 Reverse Stock Split Effective February 2024 by TipRanks Feb 15 7:19am ET Ginkgo Bioworks and Agenus subsidiary awarded MCDC vaccine contract by TipRanks Jan 25 8:00am ET Analysts Are Bullish on Top Healthcare Stocks: Agenus (AGEN), Zivo Bioscience (ZIVO) by TipRanks Jan 22 4:00pm ET Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Regeneron (REGN) and Warby Parker (WRBY) by TipRanks Jan 22 10:03am ET Agenus: Botensilimab/balstilimab data shows tumor shrinkage, biomarker response by TipRanks
Apr 08 3:34am ET Down 75%. Is Agenus Stock a Buy on the Dip? by Motley Fool Apr 03 4:19am ET 2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now? by Motley Fool Mar 14 1:30pm ET Agenus (AGEN) Q4 2023 Earnings Call Transcript by Motley Fool

No recent press releases are available for AGEN

AGEN Financials

1-year income & revenue

Key terms

AGEN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

AGEN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel
JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.
Win McNamee/Getty Images
Jamie Dimon says chance of a bad economy is ‘higher than other people think’